Table:
begin	end	state
1	20	cytoplasmic
21	43	transmembrane
44	48	non-cytoplasmic
49	68	transmembrane
69	106	cytoplasmic
107	129	transmembrane
130	134	non-cytoplasmic
135	154	transmembrane
155	164	cytoplasmic
165	187	transmembrane
188	206	non-cytoplasmic
207	232	transmembrane
233	252	cytoplasmic
253	271	transmembrane
272	289	non-cytoplasmic
290	314	transmembrane
315	338	cytoplasmic
339	360	transmembrane
361	365	non-cytoplasmic
366	387	transmembrane
388	407	cytoplasmic
408	431	transmembrane
432	436	non-cytoplasmic
437	454	transmembrane
455	474	cytoplasmic

Input:
>RR42_RS33780
MIHHQQQQQSSGLKHGLKQRHMTMIALGGVIGAGLFVGSGVVIKSAGPAAVISFLITGLL
VVLVMRMLGEMACALPTVGSFYEYAREAWSDRPAMGELAGFLTGWMYWYFWVIVVALEAV
AGASLVQFWLPGVPAWSISLVLLVMLTLTNLISVKSFGEFEFWFASIKVAAIVVFLFLAG
LFVLGMWPGATASVAHLTVHGGFAPNGIMPVLTGAVAATGFYFGAEIVTIAAAETAEPQK
AVARATSSVITRVLVFYVGSVLLVVCLVPWNSAGIATPYVSALNAMRIPAAAQIMNAVVL
TAVLSALNSGLYASSRMLFALTKRGDAPKALARLSRNGVPVRAILFATLFGYGAVVMSYV
SPDKVFAFLVNSYGTVAIFVYILIAISQLRLRARLEREAPHRLKVRMWAFPYLTWVAIAG
MVGIVVAMAFIPDQRTPLLLGVASLGILVVAYAVRQQLRKHAAAAPLGEVRRAD

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server